Page last updated: 2024-10-17

aminocaproic acid and Encephalopathy, Traumatic

aminocaproic acid has been researched along with Encephalopathy, Traumatic in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Wallen, TE1
Singer, KE1
Baucom, MR1
England, LG1
Schuster, RM1
Pritts, TA1
Goodman, MD1
Kang, DW1
Cha, BG1
Lee, JH1
Yang, W1
Ki, SK1
Han, JH1
Cho, HY1
Park, E1
Jeon, S1
Lee, SH1

Other Studies

2 other studies available for aminocaproic acid and Encephalopathy, Traumatic

ArticleYear
Effects of antifibrinolytics on systemic and cerebral inflammation after traumatic brain injury.
    The journal of trauma and acute care surgery, 2022, 07-01, Volume: 93, Issue:1

    Topics: Aminocaproic Acid; Animals; Antifibrinolytic Agents; Brain Injuries, Traumatic; Chemokine CCL2; Chem

2022
Ultrasmall polymer-coated cerium oxide nanoparticles as a traumatic brain injury therapy.
    Nanomedicine : nanotechnology, biology, and medicine, 2022, Volume: 45

    Topics: Aminocaproic Acid; Animals; Antioxidants; Brain Injuries; Brain Injuries, Traumatic; Cerium; Free Ra

2022